mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.08 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.08 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.08 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.09 |
0.08 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.08 |